AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34165523 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34464489 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally applied vaginal estrogen cream
Number of subjects: 120
Study 34464489 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 120
Study 32375334 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (70 µg)
Number of subjects: 76
Study 32375334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 35696838 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Exposure Therapy (I‐PE)
Number of subjects: 119
Study 35696838 — intervention group
Group type: COMPARATOR
Intervention: Integrated Coping Skills Therapy (I‐CS)
Number of subjects: 119
Study 35696838 — intervention group
Group type: EXPERIMENTAL
Intervention: Full Sample
Number of subjects: 119
Study 32487113 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam therapy (PBT)
Number of subjects: 0
Study 33486855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg administered immediately after surgery
Number of subjects: 38
Study 33486855 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg administered 30 min before surgery
Number of subjects: 38
Study 33486855 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative analgesic treatment group
Number of subjects: 38
Study 33486855 — intervention group
Group type: COMPARATOR
Intervention: Preoperative analgesic treatment group
Number of subjects: 38
Study 33486855 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 32144336 — intervention group
Group type: EXPERIMENTAL
Intervention: SAP P11-4 and twice fluoride varnish
Number of subjects: 90
Study 32144336 — intervention group
Group type: EXPERIMENTAL
Intervention: SAP P11-4 and twice weekly SAPM (home-application)
Number of subjects: 90
Study 32144336 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 90
Study 36214818 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified mid-urethral sling technique (mMUS)
Number of subjects: 126
Study 36214818 — intervention group
Group type: COMPARATOR
Intervention: Transobturator tape (TOT)
Number of subjects: 126
Study 33689786 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol 15 mg/drospirenone 3 mg (E4/DRSP)
Number of subjects: 82
Study 33689786 — intervention group
Group type: COMPARATOR
Intervention: Ethinylestradiol 20 µg/drospirenone 3 mg (EE/DRSP)
Number of subjects: 82
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement module
Number of subjects: 3
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation module
Number of subjects: 3
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reframing module
Number of subjects: 3
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity selection module
Number of subjects: 3
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent psychoeducation module
Number of subjects: 3
Study 36328998 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven other modules
Number of subjects: 3
Study 36076498 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin supplementation (90.2 mg daily)
Number of subjects: 217
Study 36076498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 33975075 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' voice
Number of subjects: 103
Study 33975075 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 103
Study 33975075 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 103
Study 33559524 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-210 (9 mg)
Number of subjects: 0
Study 33559524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33415874 — intervention group
Group type: EXPERIMENTAL
Intervention: Jin's three-needle combined with MyoTrac biostimulation therapy
Number of subjects: 120
Study 33415874 — intervention group
Group type: COMPARATOR
Intervention: simple Jin's three-needle therapy
Number of subjects: 120
Study 33415874 — intervention group
Group type: COMPARATOR
Intervention: simple MyoTrac biostimulation therapy
Number of subjects: 120
Study 32097391 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG) 1gr/kg
Number of subjects: 51
Study 32097391 — intervention group
Group type: COMPARATOR
Intervention: Lactulose 1cc/kg
Number of subjects: 51
Study 37449542 — intervention group
Group type: EXPERIMENTAL
Intervention: Early local radiotherapy (LRT)
Number of subjects: 0
Study 37449542 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront local radiotherapy (LRT)
Number of subjects: 0
Study 37449542 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical LRT including primary tumor surgery followed by radiotherapy (RT)
Number of subjects: 0
Study 37449542 — intervention group
Group type: EXPERIMENTAL
Intervention: LRT
Number of subjects: 0
Study 34052395 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Advanced Modular Manikin (AMM)
Number of subjects: 42
Study 34052395 — intervention group
Group type: COMPARATOR
Intervention: Peripheral simulators
Number of subjects: 42
Study 32677458 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention on heart failure self-care resources and symptom management during index admission
Number of subjects: 218
Study 32677458 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 218
Study 34936606 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (1 week after surgery)
Number of subjects: 225
Study 34032997 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 antibodies detection using FDA approved ROCHE kit
Number of subjects: 15390
Study 34032997 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 15390
Study 34032997 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger group (≤ 20 years)
Number of subjects: 15390
Study 33032071 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 20
Study 33032071 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study 34504990 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy plus ribociclib
Number of subjects: 565
Study 34504990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 565
Study 35691448 — intervention group
Group type: EXPERIMENTAL
Intervention: Local consolidative therapy (LCT) plus standard-of-care systemic therapy or observation
Number of subjects: 50
Study 35691448 — intervention group
Group type: EXPERIMENTAL
Intervention: Local consolidative therapy (LCT)
Number of subjects: 50
Study 33773533 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (counselling, intra oral camera assessment, and carbon monoxide monitoring)
Number of subjects: 0
Study 33773533 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon monoxide monitoring
Number of subjects: 0
Study 33773533 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling and intra oral camera assessment
Number of subjects: 0
Study 33773533 — intervention group
Group type: COMPARATOR
Intervention: General counselling only
Number of subjects: 0
Study 36133438 — intervention group
Group type: EXPERIMENTAL
Intervention: Periocline-assisted periodontal basic therapy
Number of subjects: 108
Study 36133438 — intervention group
Group type: COMPARATOR
Intervention: Control group (periodontal basic therapy without periocline)
Number of subjects: 108
Study 33994199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep duration
Number of subjects: 116787
Study 33994199 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia complaints
Number of subjects: 116787
Study 33994199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ease of getting up in the morning
Number of subjects: 116787
Study 34147963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 122
Study 34147963 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 122
Study 33060258 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized calfactant (Infasurf), 6 mL/kg (210 mg phospholipid/kg body weight), up to 3 treatments, at least 4 hours apart.
Number of subjects: 457
Study 33060258 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group), determined by providers.
Number of subjects: 457
Study 33060258 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized calfactant (Infasurf)
Number of subjects: 457
Study 35687033 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruptions with 1‐min light half‐squat exercises every 20 min (EX)
Number of subjects: 20
Study 35687033 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (CON)
Number of subjects: 20
Study 34347705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrashort echo time (UTE) T2? cartilage mapping
Number of subjects: 10
Study 33401223 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (AP)
Number of subjects: 18
Study 33401223 — intervention group
Group type: COMPARATOR
Intervention: Salvianolate (SV)
Number of subjects: 18
Study 33401223 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (A + S)
Number of subjects: 18
Study 33692185 — intervention group
Group type: EXPERIMENTAL
Intervention: PermaSeal (Ultradent)
Number of subjects: 140
Study 33692185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser (LLL, AsGaAl) at a wavelength of 780 nm (Laser XT Therapy, DMC, São Carlos, Brazil)
Number of subjects: 140
Study 33692185 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LLL and PermaSeal (Ultradent)
Number of subjects: 140
Study 33692185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 140
Study 32213141 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous fibre from konjac-based blend (KBB)
Number of subjects: 0
Study 36881399 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 3526
Study 36881399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3526
Study 34002374 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic generalized epilepsy (GGE)
Number of subjects: 12803
Study 34002374 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher beta and theta polygenic risk scores
Number of subjects: 12803
Study 34002374 — intervention group
Group type: EXPERIMENTAL
Intervention: GGE genetic liability
Number of subjects: 12803
Study 32979072 — intervention group
Group type: EXPERIMENTAL
Intervention: SGRQ
Number of subjects: 138
Study 35387739 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis (2 g amoxicillin 1 h before surgery)
Number of subjects: 450
Study 35387739 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose prophylactic antibiotic (2 g amoxicillin 1 h before surgery) with additional doses after surgery (500 mg amoxicillin, q8h for 5 days)
Number of subjects: 450
Study 35387739 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgical antibiotics alone (500 mg amoxicillin, q8h for 5 days)
Number of subjects: 450
Study 35387739 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 450
Study 33858400 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive home care program
Number of subjects: 116
Study 33858400 — intervention group
Group type: COMPARATOR
Intervention: Routine hospital education program
Number of subjects: 116
Study 33858400 — intervention group
Group type: COMPARATOR
Intervention: Supportive home care program vs Routine hospital education program
Number of subjects: 116
Study 34068848 — intervention group
Group type: EXPERIMENTAL
Intervention: MCAT plus Collagen Matrix (CM)
Number of subjects: 20
Study 34068848 — intervention group
Group type: COMPARATOR
Intervention: MCAT plus Subepithelial Connective Tissue Graft (SCTG)
Number of subjects: 20
Study 35762280 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial aftercare (PAC)
Number of subjects: 419
Study 35762280 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 419
Study 33767791 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg body weight)
Number of subjects: 134
Study 33767791 — intervention group
Group type: COMPARATOR
Intervention: Nesdonal (3-5 mg/kg body weight)
Number of subjects: 134
Study 616118926 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mm diameter implant
Number of subjects: 32
Study 35098466 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg Cd/kg of feed
Number of subjects: 72
Study 35098466 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Cd/kg of feed
Number of subjects: 72
Study 35098466 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Cd/kg of feed
Number of subjects: 72
Study 35098466 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet without additional Cd)
Number of subjects: 72
Study 35555782 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation (2000 IU/d vitamin D3 and 1500 mg/d calcium)
Number of subjects: 2109
Study 35555782 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no vitamin D and calcium supplementation)
Number of subjects: 2109
Study 35749758 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 10 mg
Number of subjects: 32
Study 35749758 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 20 mg
Number of subjects: 32
Study 35749758 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 30 mg
Number of subjects: 32
Study 35749758 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study 35749758 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (ZOL) 30 mg
Number of subjects: 32
Study 35749758 — intervention group
Group type: EXPERIMENTAL
Intervention: Suvoxexant (SUV) 40 mg
Number of subjects: 32
Study 32967921 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (DM+MF)
Number of subjects: 123
Study 32967921 — intervention group
Group type: COMPARATOR
Intervention: DM-noMF (Control)
Number of subjects: 123
Study 35822924 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously every 4 weeks for 52 weeks
Number of subjects: 407
Study 35822924 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 407
Study 35822924 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously
Number of subjects: 407
Study 34455849 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated antiplatelet therapy (APT) for 5 months in patients with OAC indication; 11 months in patients without OAC indication.
Number of subjects: 4579
Study 34455849 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated APT for patients without OAC indication.
Number of subjects: 4579
Study 34455849 — intervention group
Group type: COMPARATOR
Intervention: Nonabbreviated APT for patients with OAC indication; ≥2 months dual APT followed by single APT.
Number of subjects: 4579
Study 34455849 — intervention group
Group type: COMPARATOR
Intervention: Nonabbreviated APT for patients without OAC indication; ≥5 months dual APT followed by single APT.
Number of subjects: 4579
Study 33059457 — intervention group
Group type: EXPERIMENTAL
Intervention: WASH interventions
Number of subjects: 640
Study 33059457 — intervention group
Group type: COMPARATOR
Intervention: Non-WASH schools
Number of subjects: 640
Study 36002048 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of NL003
Number of subjects: 540
Study 36002048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 33521871 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 40 group
Number of subjects: 2282
Study 33521871 — intervention group
Group type: COMPARATOR
Intervention: BMI < 40 group
Number of subjects: 2282
Study 32917601 — intervention group
Group type: EXPERIMENTAL
Intervention: Political advertisements
Number of subjects: 34000
Study 34618907 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT‐I + Light
Number of subjects: 101
Study 34618907 — intervention group
Group type: COMPARATOR
Intervention: TAU+
Number of subjects: 101
Study 32097932 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 8782
Study 32097932 — intervention group
Group type: COMPARATOR
Intervention: Bare-Metal Stent (BMS)
Number of subjects: 8782
Study 35507141 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 120
Study 35507141 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline plus oral acetazolamide (5 mg/kg/day)
Number of subjects: 120
Study 35507141 — intervention group
Group type: COMPARATOR
Intervention: Half saline plus 75 mEq/L sodium bicarbonate
Number of subjects: 120
Study 34193503 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily PEP flute usage as add-on to usual care
Number of subjects: 400
Study 34193503 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 400
Study 32875927 — intervention group
Group type: EXPERIMENTAL
Intervention: Past sodium intake (tertile 3)
Number of subjects: 1191
Study 32875927 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary sodium intake (tertile 3)
Number of subjects: 1191
Study 35713760 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 281
Study 35713760 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 281
Study 35713760 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 281
Study 33407760 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression approach for personalised treatment recommendation
Number of subjects: 0
Study 33407760 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of Kraemer’s approach
Number of subjects: 0
Study 33407760 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression method
Number of subjects: 0
Study 33407760 — intervention group
Group type: COMPARATOR
Intervention: Kraemer’s approach
Number of subjects: 0
Study 33753890 — intervention group
Group type: EXPERIMENTAL
Intervention: HE&PA combined
Number of subjects: 0
Study 32914421 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic navigation system
Number of subjects: 6
Study 32914421 — intervention group
Group type: COMPARATOR
Intervention: Traditional freehand protocol
Number of subjects: 6
Study 32244495 — intervention group
Group type: EXPERIMENTAL
Intervention: Arrowhead Business Group (ABG) entrepreneurship education program
Number of subjects: 394
Study 32244495 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 394
Study 35877214 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Drain Coaxial tube (SDC group)
Number of subjects: 98
Study 35877214 — intervention group
Group type: COMPARATOR
Intervention: Standard chest tube (ST group)
Number of subjects: 98
Study 34313633 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced vasodilation treatment (EVT) based on renin‐angiotensin blockade and/or amlodipine
Number of subjects: 81
Study 34313633 — intervention group
Group type: COMPARATOR
Intervention: Reduced vasodilation treatment (RVT) based on nonvasodilating β‐blockade (metoprolol)
Number of subjects: 81
Study 32887596 — intervention group
Group type: EXPERIMENTAL
Intervention: Freire's Adult Education Model (FAEM) intervention
Number of subjects: 132
Study 32887596 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 132
Study 36065593 — intervention group
Group type: EXPERIMENTAL
Intervention: Penalised maximum likelihood estimate (MLE)
Number of subjects: 0
Study 36065593 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional maximum likelihood estimate (MLE)
Number of subjects: 0
Study 36065593 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary analysis
Number of subjects: 0
Study 33657403 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy
Number of subjects: 0
Study 33657403 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with rivaroxaban and an antiplatelet agent
Number of subjects: 0
Study 36318919 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial meal replacement plan (2 meal replacement shakes plus a healthy meal for 3 months)
Number of subjects: 153
Study 36318919 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial meal replacement plan
Number of subjects: 153
Study 32293463 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT) during pulmonary rehabilitation (PR)
Number of subjects: 44
Study 32293463 — intervention group
Group type: COMPARATOR
Intervention: Non-high-flow nasal therapy (non-HFNT) during pulmonary rehabilitation (PR)
Number of subjects: 44
Study 34906660 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) delivered via mobile phone messaging for 14 days, twice daily messages
Number of subjects: 90
Study 34906660 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 90
Study 34906660 — intervention group
Group type: COMPARATOR
Intervention: Control group (no messages)
Number of subjects: 90
Study 32633899 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbopelvic tilt motor training task
Number of subjects: 30
Study 32633899 — intervention group
Group type: COMPARATOR
Intervention: Finger abduction control task
Number of subjects: 30
Study 33338430 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory-motor training to distinguish mirror letters (e.g., 'b' vs 'd') for 7.5 hours combined with post-training sleep.
Number of subjects: 0
Study 33338430 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-training sleep enhancement of learning consolidation.
Number of subjects: 0
Study 33338430 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal approach targeting mirror invariance inhibition.
Number of subjects: 0
Study 33338430 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials.
Number of subjects: 0
Study 33047586 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine mesoappendixectomy, restrictive strategy for abdominal drainage, and postoperative antibiotic prevention (main group)
Number of subjects: 127
Study 33047586 — intervention group
Group type: COMPARATOR
Intervention: Mesoappendixectomy only in case of necrotic changes (control group)
Number of subjects: 127